Prognostic significance of solitary lymph node metastasis in patients with squamous cell carcinoma of middle thoracic esophagus

World Journal of Surgical Oncology

Li-Song Teng²  Mark J Krasna³  Wei-Ming Mao¹  Xing-Ming Zhou¹  Qi-Xun Chen¹  Jie Wu¹ 

[1] Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, China;Department of Surgical Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310033, China;Meridian Cancer Care, Jersey Shore University Medical Center, Neptune, NJ, 07753, USA

关键词: Lymphadenectomy;    Prognosis;    Solitary lymph node;    Esophageal cancer;   

Others  :  827164
DOI  :  10.1186/1477-7819-10-210

 received in 2012-08-12, accepted in 2012-09-18,  发布年份 2012

【 摘 要 】

Background

The aim of this study is to compare clinical outcomes between patients with solitary lymph node metastasis and node-negative (N0) patients in squamous cell carcinoma of the middle thoracic esophagus.

Methods

A series of 135 patients with squamous cell carcinoma of the middle thoracic esophagus were retrospectively investigated. There were 33 patients with solitary lymph node metastasis and 102 N0 patients. Skip metastasis in 33 patients with solitary lymph node metastasis was defined according to three criteria: Japanese Society for Esophageal Disease (JSED), American Joint Commission on Cancer (AJCC), and the anatomical compartment.

Results

In 33 patients with solitary lymph node metastasis, skip metastasis was shown in 13, 23, and 8 patients according JSED, AJCC and anatomical compartment respectively. The 5-year survival rates for N0 patients and patients with solitary lymph node metastasis were 58% and 32% respectively (P =0.008). Multivariate analysis revealed that skip metastasis was not an independent prognostic factor.

Conclusions

For patients with middle thoracic esophageal squamous cell carcinoma, solitary lymph node metastasis has a negative impact on survival compared with N0 disease; skip metastasis, however, is comparable to N0 diseases in predicting prognosis.

【 授权许可】

   
2012 Wu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Chen J, Liu S, Pan J, Zheng X, Zhu K, Zhu J, Xiao J, Ying M: The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2009, 36:480-486.
• [2]Schröder W, Prenzel K, Baldus SE, Mönig SP, Schneider PM, Hölscher AH: Localization of isolated lymph node metastases in esophageal cancer–does it influence the sentinel node concept? Hepatogastroenterology 2007, 54:1116-1120.
• [3]Takeuchi H, Fujii H, Ando N, Ozawa S, Saikawa Y, Suda K, Oyama T, Mukai M, Nakahara T, Kubo A, Kitajima M, Kitagawa Y: Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 2009, 249:757-763.
• [4]Matsubara T, Ueda M, Kaisaki S, Kuroda J, Uchida C, Kokudo N, Takahashi T, Nakajima T, Yanagisawa A: Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer 2000, 89:1869-1873.
• [5]Kunisaki C, Makino H, Kimura J, Oshima T, Fujii S, Takagawa R, Kosaka T, Ono H, Akiyama H, Endo I: Therapeutic strategy for esophageal cancer based on solitary lymph node metastasis. Hepatogastroenterology 2011, 58:1561-1565.
• [6]Natsugoe S, Matsumoto M, Okumura H, Nakashima S, Higashi H, Uenosono Y, Ehi K, Ishigami S, Takao S, Aikou T: Initial metastatic, including micrometastatic, sites of lymph nodes in esophageal squamous cell carcinoma. J Surg Oncol 2005, 89:6-11.
• [7]Prenzel KL, Bollschweiler E, Schröder W, Mönig SP, Drebber U, Vallboehmer D, Hölscher AH: Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 2010, 90:1662-1667.
• [8]Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shuto K, Shimizu T, Akutsu Y, Tanizawa Y, Hayashi H, Ochiai T: Location and clinical impact of solitary lymph node metastasis in patients with thoracic esophageal carcinoma. Am J Surg 2006, 192:306-310.
• [9]Lin CS, Chang SC, Wei YH, Chou TY, Wu YC, Lin HC, Wang LS, Hsu WH: Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 2009, 87:1056-1065.
• [10]Rice TW, Blackstone EH, Rusch VW: 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010, 17:1721-1724.
• [11]Peyre CG, Hagen JA, DeMeester SR, Van Lanschot JJ, Hölscher A, Law S, Ruol A, Ancona E, Griffin SM, Altorki NK, Rice TW, Wong J, Lerut T, DeMeester TR: Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008, 248:979985.
• [12]American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th edition. Philadelphia: Lippincott-Raven; 2002.
• [13]Japanese Society for Esophageal Diseases: Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 9th edition edition. Tokyo: Kanehara & Co, Ltd; 2001.
• [14]Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
• [15]Peto R: Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J. Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977, 35:1-39.
• [16]Cox DR: Statistical significance tests. Br J Clin Pharmacol 1982, 14:325-331.
• [17]O'Riordan JM, Rowley S, Murphy JO, Ravi N, Byrne PJ, Reynolds JV: Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction. J Gastrointest Surg 2007, 11:493-499.
• [18]Hosch SB, Stoecklein NH, Pichlmeier U, Rehders A, Scheunemann P, Niendorf A, Knoefel WT, Izbicki JR: Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001, 19:1970-1975.
• [19]Tachimori Y, Nagai Y, Kanamori N, Hokamura N, Igaki H: Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus 2011, 24:33-38.
• [20]Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, Minamiya Y, Ogawa J: Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and T2-4 thoracic squamous cell esophageal cancers. World J Surg 2009, 33:512-517.
• [21]Darling G: The role of lymphadenectomy in esophageal cancer. J Surg Oncol 2009, 99:189-193.
• [22]Jamieson GG, Lamb PJ, Thompson SK: The role of lymphadenectomy in esophageal cancer. Ann Surg 2009, 250:206-209.